Donald Meichenbaum, Ph.D., is Distinguished Professor Emeritus, University of Waterloo, Ontario, Canada and Research Director of The Melissa Institute for Violence Prevention and Treatment of Victims of Violence, (www.melissainstitute.org). Dr. Meichenbaum was instrumental in developing www.warfighterdiaries.com which is an IPOD technology for soldiers and their families. He is one of the founders of cognitive-behavioral therapy (CBT) and in an American Psychologist survey was voted “one of the ten most influential psychotherapists of the century”.

Dr. Meichenbaum's prolific work has been published in numerous journals, chapters, and books. His books include Cognitive Behavior Modification: An Integrative Approach, Stress Inoculation Training, Pain and Behavioral Medicine, Facilitating Treatment Adherence: A Practitioner's Guidebook, Treating Adults with Post-Traumatic Stress Disorder, and most recently a clinical handbook on Treatment of Individuals with Anger-Control Problems and Aggressive Behaviors. For his exceptional teaching skills, Dr. Meichenbaum was awarded the prestigious NEEI Mental Health Educator of the Year award in 2000. For his contributions to the field of psychology, Dr. Meichenbaum was honored in 2008 with a Lifetime Achievement Award from Division 12 of the American Psychological Association.

Substance Abuse Disorders (SUDs) are prevalent among individuals with psychiatric disorders, ranging from 20% to 70%, but SUDs are often under-identified and under-treated in psychiatric patients, and similarly, psychiatric disorders are not adequately addressed in substance abuse treatment centers. In this advanced workshop, specific therapy skills will be discussed, modeled and practiced for the integrative treatment of patients with internalizing problems and externalizing problems. A self-assessment Therapist's Checklist will be used to self-evaluate attendees' knowledge and level of expertise. Partcipants will learn how to use an integrative phase-oriented treatment approach with such varied dually diagnosed clinical populations as returning veterans, patients who are in residential treatment settings, and with unmotivated, mandated, treatment-resistant challenging clients.